Canaccord’s Richard Davis anticipates VEEV stock can move up consistently sometime by the first half of next year.
Oppenheimer’s Andrew Uerkwitz feels the need to temper expectations by telling investors Ambarella is still a risky play near-term.
Nutanix receives a bullish report from Oppenheimer’s Ittai Kidron based on the company’s strong earnings and outlook.
Today, shareholders of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) woke up to a nice 4% pop in the value of their shares. The …
Marathon Patent Group Inc (NASDAQ:MARA) announced its operating results for the three months ended September 30, 2017, as published in its Quarterly Report …
Salesforce.com, inc.
Baozun Inc (ADR) (NASDAQ:BZUN) reported its third-quarter results on Tuesday beating the consensus estimates on the top and bottom line. Despite the earnings …
DryShips (NASDAQ:DRYS) just announced its third-quarter earnings results that failed to live up to Wall Street’s expectations. The stock is down nearly 10% in …
Oppenheimer’s Shaul Eyal now sees 17% upside potential for PANW on back of a powerhouse earnings outclass and full-year guidance raise for fiscal 2018.
Even as Drexel Hamilton’s Brian White lowers his SaaS growth expectations for next two fiscal years, the analyst is enticed by market share prospects ahead.
